Caldwell Sutter Capital’s Biogen BIIB Stock Holding History

Caldwell Sutter Capital’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.48K	Hold	30	–	–	﹤0.01%	656
2026 Q1	$5.5K	Hold	30	–	–	﹤0.01%	631
2025 Q4	$5.28K	Sell	30 -4	-12%	-$653	﹤0.01%	627
2025 Q3	$4.76K	Hold	34	–	–	﹤0.01%	638
2025 Q2	$4.27K	Hold	34	–	–	﹤0.01%	632
2025 Q1	$4.65K	Hold	34	–	–	﹤0.01%	634
2024 Q4	$5.2K	Hold	34	–	–	﹤0.01%	632
2024 Q3	$6.59K	Hold	34	–	–	﹤0.01%	607
2024 Q2	$7.88K	Hold	34	–	–	﹤0.01%	578
2024 Q1	$7.33K	Hold	34	–	–	﹤0.01%	581
2023 Q4	$8.8K	Hold	34	–	–	﹤0.01%	559
2023 Q3	$8.74K	Hold	34	–	–	﹤0.01%	544
2023 Q2	$9.69K	Sell	34 -21	-38%	-$6.25K	0.01%	532
2023 Q1	$15.3K	Buy	+55	New	+$15.2K	0.01%	366

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Caldwell Sutter Capital's BIIB Position: Q2 2026 in Review

Caldwell Sutter Capital held its Biogen (BIIB) position steady in Q2 2026 at 30 shares worth $6.48K. The position accounts for ﹤0.01% of the portfolio, ranked #656.

Caldwell Sutter Capital first reported a position in BIIB in Q1 2023 and has held it in 14 quarters since. The position peaked at $15.3K in Q1 2023. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Caldwell Sutter Capital held 30 shares of Biogen worth $6.48K as of Q2 2026.
Caldwell Sutter Capital left its Biogen share count unchanged in Q2 2026.
Biogen made up ﹤0.01% of Caldwell Sutter Capital's portfolio in Q2 2026, its #656 holding.
Caldwell Sutter Capital first reported a position in Biogen in Q1 2023 and has held it in 14 quarters since.
Caldwell Sutter Capital's Biogen position peaked at $15.3K in Q1 2023.
1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Caldwell Sutter Capital's 13F filing for Q2 2026, filed 5 Aug 2026.